MetLife Inc. Reports New Financial Obligation

TL;DR

MetLife just took on a new debt, filing an 8-K on 9/26.

AI Summary

On September 26, 2024, MetLife Inc. filed an 8-K report detailing a direct financial obligation. The filing indicates the creation of a new financial obligation for the company, though specific details regarding the amount or nature of this obligation are not provided in the excerpt.

Why It Matters

This filing signals a new financial commitment for MetLife, which could impact its balance sheet and future financial flexibility.

Risk Assessment

Risk Level: medium — The creation of a new financial obligation, without immediate details on its size or terms, introduces a degree of uncertainty regarding MetLife's financial health.

Key Players & Entities

• METLIFE INC (company) — Registrant
• September 26, 2024 (date) — Date of earliest event reported
• 200 Park Avenue, New York, New York 10166-0188 (address) — Principal executive office address

FAQ

Key Financial Figures

• $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating
• $250,000,000 — 4, MetLife, Inc. (the "Company") issued $250,000,000 in additional aggregate principal amoun
• $500,000,000 — to which the Company previously issued $500,000,000 aggregate principal amount of its 5.300

Filing Documents

• d856287d8k.htm (8-K) — 38KB
• d856287dex11.htm (EX-1.1) — 234KB
• d856287dex12.htm (EX-1.2) — 35KB
• d856287dex43.htm (EX-4.3) — 95KB
• d856287dex51.htm (EX-5.1) — 14KB
• g856287g0927121937329.jpg (GRAPHIC) — 4KB
• g856287g0927132735006.jpg (GRAPHIC) — 3KB
• 0001193125-24-229033.txt ( ) — 678KB
• met-20240926.xsd (EX-101.SCH) — 4KB
• met-20240926_def.xml (EX-101.DEF) — 14KB
• met-20240926_lab.xml (EX-101.LAB) — 23KB
• met-20240926_pre.xml (EX-101.PRE) — 15KB
• d856287d8k_htm.xml (XML) — 8KB

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description of Exhibit 1.1 Underwriting Agreement, dated as of September 26, 2024, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule I to the Pricing Agreement. 1.2 Pricing Agreement, dated September 26, 2024, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. 4.1 Senior Indenture, dated as of November 9, 2001, between the Company and the Trustee (incorporated by reference to Exhibit 4.1(a) to the Company's Annual Report on Form 10-K for the year ended December 31, 2011). 4.2 Forty-Sixth Supplemental Indenture, dated as of June 5, 2024, between the Company and the Trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on June 5, 2024). 4.3 Forty-Seventh Supplemental Indenture, dated as of September 30, 2024, between the Company and the Trustee. 4.4 Form of Senior Note (included as Exhibit A to Exhibit 4.3 above). 5.1 Opinion Letter of Willkie Farr & Gallagher LLP relating to the validity of the New Senior Notes. 23.1 Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1 above). 101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. METLIFE, INC. Date: September 30, 2024 By: /s/ Tamara L. Schock Name: Tamara L. Schock Title: Executive Vice Presid

View Full Filing

View this 8-K filing on SEC EDGAR